monarch external trigeminal nerve stimulation (etns) system (NeuroSigma)
Structured Review
Monarch External Trigeminal Nerve Stimulation (Etns) System, supplied by NeuroSigma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/trigeminal+nerve+stimulation/trigeminal+nerve+stimulation/pm40086372-88-7-14
Average 90 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: The potential use of trigeminal nerve stimulation in the treatment of epilepsy. Article Snippet: Financial & competing interests disclosure IA Cook, CP Kealey and CM DeGiorgio are named as inventors on patents and/or patent applications concerning trigeminal nerve stimulation that they assigned to the Regents of the Uni- versity of California (UC) and/or Article Title: Issue Overview Article Snippet: Learning Objectives Upon completion of the Continuum: Lifelong Learning in Neurology Epilepsy issue, participants will be able to: ► Discuss the controversy regarding the terminology for seizures and epilepsy and describe the newly proposed classification ► Apply strategies for the diagnosis and evaluation of patients with seizure disorders using EEG and neuroimaging techniques ► Treat patients with seizures and epilepsy using antiepileptic drug therapy ► Recognize important therapeutic issues in pediatric epilepsy ► Identify patients nonepileptic behavioral disorders and best treatment approaches for them, including cognitive behavioral therapy ► Manage patients with acute repetitive seizures and status epilepticus ► Identify individuals with surgically remediable epileptic syndromes who may be candidates for epilepsy surgery and realize when referral for surgery should be considered Article Title: Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder. Article Snippet: Objectives: External stimulation of the trigeminal nerve (eTNS) is an emerging neuromodulation therapy for epilepsy and depression.. Preliminary studies suggest it has an excellent safety profile and is associated with significant improvements in seizures and mood.. Neuroanatomical projections of the trigeminal system suggest eTNS may alter activity in structures regulating mood, anxiety, and sleep. Article Title: Implantable electroacupuncture device and method for treating depression, bipolar disorder and anxiety Article Snippet: The therapy platforms used by Article Title: Contributors Article Snippet: Professor of Neurology, University of South Florida, Tampa, Florida; Director, Comprehensive Epilepsy Program, Tampa General Hospital, Tampa, Florida *Dr Benbadis is a member of the speakers bureau and serves as a consultant for Cyberonics, Inc, GlaxoSmithKline, Lundbeck, Supernus Pharmaceuticals, Inc, and UCB; serves as an editor for Medscape-WebMD, LLC; and receives research support from Lundbeck, Sunovion Pharmaceuticals, Inc, Supernus Pharmaceuticals, Inc, and UCB.. †Dr Benbadis reports no disclosure.. LIFELONG LEARNING IN NEUROLOGY® Article Title: Epilepsy & behavior: 15th anniversary research on omega-3 fatty acids for epilepsy. Article Snippet: The authors congratulate Dr. Steven Schachter and the editorial board on the 15th anniversary of Epilepsy & Behavior.. Epilepsy & Behavior has taken the lead in publishing early research on alternative treatments for epilepsy and has provided a podium in which basic and translational research could be rapidly reported.. Over time, the quality of papers and the impact of the journal have increased, and Epilepsy & Behavior has become a go-to journal for cutting-edge research on epilepsy. Article Title: The SUDEP Risk Inventory: Association with postictal generalized EEG suppression. Article Snippet: To help identify patients at greatest risk for sudden unexpected death in epilepsy (SUDEP), screening inventories like the SUDEP-7 Inventory can be useful.. In this study, we examined the strength of association between this inventory’s risk factors and postictal generalized EEG suppression (PGES), a biomarker of SUDEP risk.. We reanalyzed data from an epilepsy monitoring unit study of 37 children. Article Title: An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder. Article Snippet: Background: This study examined the potential feasibility and utility of trigeminal nerve stimulation (TNS) for attention-deficit/hyperactivity disorder (ADHD) in youth.. Methods: Twenty-four participants ages 7e14 with ADHD enrolled in an 8-week open trial of TNS administered nightly during sleep, and were assessed weekly with parentand physician-completed measures of ADHD symptoms and executive functioning as well as measures of treatment compliance, adverse events, and side effects.. Computerized tests of cognitive functioning were administered at baseline and weeks 4 and 8. |
